Trials / Unknown
UnknownNCT02597829
Does Clinical Response Correlate With Serum Certolizumab Levels?
Does Clinical Response Correlate With Serum Certolizumab Levels? A Prospective Open Label Trial of Adult Patients With Active Crohn's Disease (APOLLO)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Shafran Gastroenterology Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A prospective open label trial of adult patients with active Crohn's disease to determine if plasma concentrations of certolizumab pegol correlate to mucosal healing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Certolizumab Pegol | Subcutaneous Injection |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2018-05-01
- Completion
- 2018-10-01
- First posted
- 2015-11-05
- Last updated
- 2015-11-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02597829. Inclusion in this directory is not an endorsement.